Paper37282016
DEVELOPMENT OF ENDOTHELIA AND ERYTHROID CELLS IN THE MOUSE METANEPHROGENIC MESENCHYME IN CULTURE WITH THE FETAL LIVER.
Emura M and 1 other. Dev Growth Differ, 1972. Cited by 11 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. DEVELOPMENT OF ENDOTHELIA AND ERYTHROID CELLS IN THE MOUSE METANEPHROGENIC MESENCHYME IN CULTURE WITH THE FETAL LIVER. Papers, record 37282016. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/37282016
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- DEVELOPMENT OF ENDOTHELIA AND ERYTHROID CELLS IN THE MOUSE METANEPHROGENIC MESENCHYME IN CULTURE WITH THE FETAL LIVER.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Cited by2
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 11 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 7,129,481 | Metanephric development in serum-free organ culture. | In Vitro | 1982 | https://conductscience.org/library/papers/7129481 | PubMed |
| 175,592 | Attempts to induce tubular deformations and subsequent mixed tumours from organotypic cultures of mouse renal mesenchyma. | Z Krebsforsch Klin Onkol Cancer Res Clin Oncol | 1976 | https://conductscience.org/library/papers/175592 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/37282016
GET https://conductscience.org/api/papers/v1/37282016/authors